Showing 1 - 20 results of 46 for search 'Zahir Amoura', query time: 0.08s
Refine Results
-
1
15 Strategies for minimizing corticosteroid exposure in SLE by Zahir Amoura
Published 2021-04-01Article -
2
13 Can we withdraw low-dose prednisone in remitted patients? by Zahir Amoura
Published 2020-09-01Article -
3
-
4
-
5
18 Rare disease manifestations in SLE by Richard Furie, Zahir Amoura, David Isenberg
Published 2020-09-01Article -
6
-
7
-
8
-
9
-
10
Ivermectin as a potential treatment for COVID-19? by Olivier Chosidow, Charlotte Bernigaud, Didier Guillemot, Bruno Giraudeau, Anne Lespine, Jean-Pierre Changeux, Hervé Bourhy, Marc Lecuit, Zahir Amoura
Published 2021-06-01
Article -
11
-
12
-
13
-
14
Cerebral Vein Thrombosis in the Antiphospholipid Syndrome: Analysis of a Series of 27 Patients and Review of the Literature by Alba Jerez-Lienas, Alexis Mathian, Jenifer Aboab, Isabelle Crassard, Miguel Hie, Fleur Cohen-Aubart, Julien Haroche, Denis Wahl, Ricard Cervera, Zahir Amoura
Published 2021-12-01
Article -
15
Regulatory T Cell Responses to High-Dose Methylprednisolone in Active Systemic Lupus Erythematosus. by Alexis Mathian, Romain Jouenne, Driss Chader, Fleur Cohen-Aubart, Julien Haroche, Jehane Fadlallah, Laetitia Claër, Lucile Musset, Guy Gorochov, Zahir Amoura, Makoto Miyara
Published 2015-01-01
Article -
16
-
17
Exhausted cytotoxic control of Epstein-Barr virus in human lupus. by Martin Larsen, Delphine Sauce, Claire Deback, Laurent Arnaud, Alexis Mathian, Makoto Miyara, David Boutolleau, Christophe Parizot, Karim Dorgham, Laura Papagno, Victor Appay, Zahir Amoura, Guy Gorochov
Published 2011-10-01
Article -
18
Safety and efficacy of low-dose intravenous arsenic trioxide in systemic lupus erythematosus: an open-label phase IIa trial (Lupsenic) by Mohamed Hamidou, Antoine Néel, Joel Poupon, Zahir Amoura, Mikael Ebbo, Jean Sibilia, Jean-Francois Viallard, Benjamin Gaborit, Christelle Volteau, Jean Benoit Hardouin, Eric Hachulla, François Rieger
Published 2021-03-01
Article -
19
Identification of natural killer markers associated with fatal outcome in COVID-19 patients by Nadine Tarantino, Elena Litvinova, Elena Litvinova, Assia Samri, Cathia Soulié, Véronique Morin, Alice Rousseau, Karim Dorgham, Christophe Parizot, Olivia Bonduelle, Alexandra Beurton, Alexandra Beurton, Makoto Miyara, Makoto Miyara, Pascale Ghillani, Julien Mayaux, Raphael Lhote, Jean-Marc Lacorte, Jean-Marc Lacorte, Anne-Geneviève Marcelin, Zahir Amoura, Zahir Amoura, Charles-Edouard Luyt, Charles-Edouard Luyt, Guy Gorochov, Guy Gorochov, Amélie Guihot, Amélie Guihot, Vincent Vieillard
Published 2023-06-01
Article -
20
Lower Rate of Daily Smokers With Symptomatic COVID-19: A Monocentric Self-Report of Smoking Habit Study by Makoto Miyara, Florence Tubach, Valérie Pourcher, Capucine Morélot-Panzini, Julie Pernet, Julien Haroche, Said Lebbah, Elise Morawiec, Guy Gorochov, Eric Caumes, Pierre Hausfater, Alain Combes, Thomas Similowski, Zahir Amoura
Published 2022-01-01
Article